Kimberly-Clark Corp. shares fell the most in a quarter century after agreeing to buy Kenvue Inc., whose biggest product, ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

Household products company Kimberly-Clark (NYSE:KMB) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 17.2% year on year to $4.16 billion. Its non-GAAP profit of $1.92 ...

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

We think that Colgate-Palmolive (NYSE:CL) currently is a better pick compared to Kimberly-Clark (NYSE:KMB). CL stock trades at just under 4x trailing revenues, more than KMB’s 2.3x multiple. Does this ...

Household products company Kimberly-Clark (NYSE:KMB) will be reporting earnings this Friday before market hours. Here’s what to expect. Kimberly-Clark missed analysts’ revenue expectations by 1% last ...